Status:
COMPLETED
Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan
Lead Sponsor:
Bayer
Conditions:
Hyperphosphatemia
Eligibility:
All Genders
13+ years
Brief Summary
This study is a regulatory post marketing surveillance in Japan, and it is a local prospective and observational study of patients in continuous ambulatory peritoneal dialysis (CAPD) who have received...
Eligibility Criteria
Inclusion
- Patients undergoing continuous ambulatory peritoneal dialysis who received Fosrenol for hyperphosphatemia
Exclusion
- Patients who are contraindicated based on the product label
Key Trial Info
Start Date :
April 7 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
446 Patients enrolled
Trial Details
Trial ID
NCT01412398
Start Date
April 7 2009
End Date
September 1 2016
Last Update
January 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Locations, Japan